HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

5th Edition of International Heart Congress

June 24-26, 2027 | Hybrid Event

June 24 -26, 2027 | Rome, Italy

Bradycardia

Bradycardia

Bradycardia is a medical condition distinguished by a heart rate that is slower than the normal range, typically registering at less than 60 beats per minute. This condition may result from various factors, such as aging, heart damage, or certain medications. While some individuals with bradycardia may not experience any symptoms, others might feel fatigued, dizzy, or lightheaded. Severe bradycardia can lead to complications, affecting the heart's ability to pump an adequate amount of blood to the body. Diagnosis often involves an electrocardiogram (ECG) to assess the heart's electrical activity. Treatment options vary and depend on the underlying cause; they may include lifestyle modifications, medications, or, in severe cases, the implantation of a pacemaker to regulate the heart rate. Regular monitoring and consultation with a healthcare professional are essential for individuals diagnosed with bradycardia to manage and address any potential health risks associated with this condition.

Committee Members
Speaker at International Heart Congress 2027 - Federico Benetti

Federico Benetti

Benetti Foundation, Argentina
Speaker at International Heart Congress 2027 - Mekhman N Mamedov

Mekhman N Mamedov

National Research Center for Preventive Medicine, Russian Federation
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Heart Congress 2027 Speakers
Speaker at International Heart Congress 2027 - Federico Benetti

Federico Benetti

Benetti Foundation, Argentina
Speaker at International Heart Congress 2027 - Mekhman N Mamedov

Mekhman N Mamedov

National Research Center for Preventive Medicine, Russian Federation
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Speaker at International Heart Congress 2027 - Uwe Peter Tigor

Uwe Peter Tigor

Auxilius Pharma, United States

Submit your abstract Today

Watsapp